1. Home
  2. GKOS vs STVN Comparison

GKOS vs STVN Comparison

Compare GKOS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • STVN
  • Stock Information
  • Founded
  • GKOS 1998
  • STVN 1949
  • Country
  • GKOS United States
  • STVN Italy
  • Employees
  • GKOS N/A
  • STVN N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • STVN Containers/Packaging
  • Sector
  • GKOS Health Care
  • STVN Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • STVN Nasdaq
  • Market Cap
  • GKOS 7.4B
  • STVN 6.2B
  • IPO Year
  • GKOS 2015
  • STVN 2021
  • Fundamental
  • Price
  • GKOS $146.25
  • STVN $23.67
  • Analyst Decision
  • GKOS Strong Buy
  • STVN Buy
  • Analyst Count
  • GKOS 13
  • STVN 6
  • Target Price
  • GKOS $143.00
  • STVN $27.50
  • AVG Volume (30 Days)
  • GKOS 496.0K
  • STVN 343.4K
  • Earning Date
  • GKOS 11-04-2024
  • STVN 11-05-2024
  • Dividend Yield
  • GKOS N/A
  • STVN 0.24%
  • EPS Growth
  • GKOS N/A
  • STVN N/A
  • EPS
  • GKOS N/A
  • STVN 0.48
  • Revenue
  • GKOS $360,347,000.00
  • STVN $1,220,254,294.00
  • Revenue This Year
  • GKOS $22.68
  • STVN $3.01
  • Revenue Next Year
  • GKOS $24.98
  • STVN $7.16
  • P/E Ratio
  • GKOS N/A
  • STVN $49.11
  • Revenue Growth
  • GKOS 18.70
  • STVN 3.53
  • 52 Week Low
  • GKOS $74.75
  • STVN $16.56
  • 52 Week High
  • GKOS $147.65
  • STVN $34.73
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 59.18
  • STVN 77.49
  • Support Level
  • GKOS $137.60
  • STVN $19.25
  • Resistance Level
  • GKOS $147.65
  • STVN $24.90
  • Average True Range (ATR)
  • GKOS 4.74
  • STVN 1.02
  • MACD
  • GKOS 0.29
  • STVN 0.38
  • Stochastic Oscillator
  • GKOS 91.36
  • STVN 78.23

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: